Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.ABSTRACTUsing numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative instantaneous reproduction numbers (RRI) of the R.1, Alpha, and Delta variants with respect to other strains circulating in Japan were estimated at 1.25, 1.44, and 1.95. Depending on the assumed serial interval distributions, RRI varies from 1.20-1.32 for R.1, 1.34-1.58 for Alpha, and 1.70-2.30 for Delta. The frequency of Delta is expected to take over Alpha in Japan before 23 July 2021.PMID:34240695 | DOI:10.2807/1560-7917.ES.2021.26.27.2100570 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Kimihito Ito Chayada Piantham Hiroshi Nishiura Source Type: research

Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
ConclusionNanopore metagenomic sequencing can detect the emergence of novel variants and drug resistance, providing timely insights into antimicrobial stewardship and vaccine design. Full genome generation can help investigate and manage nosocomial outbreaks.PMID:34240696 | DOI:10.2807/1560-7917.ES.2021.26.27.2000004 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Yifei Xu Kuiama Lewandowski Louise O Downs James Kavanagh Thomas Hender Sheila Lumley Katie Jeffery Dona Foster Nicholas D Sanderson Ali Vaughan Marcus Morgan Richard Vipond Miles Carroll Timothy Peto Derrick Crook A Sarah Walker Philippa C Matthews Steve Source Type: research

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100568.ABSTRACTWe compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Dung Nguyen Peter Simmonds Maurice Steenhuis Elise Wouters Daniel Desmecht Mutien Garigliany Marta Romano Cyril Barbezange Piet Maes Bram Van Holm Joaqu ín Mendoza Salvador Oyonarte Anders Fomsgaard Ria Lassauni ère Eva Zusinaite Katarina Resman Rus Tat Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2107081.NO ABSTRACTPMID:34240698 | DOI:10.2807/1560-7917.ES.2021.26.27.2107081 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100626.ABSTRACTWe investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.PMID:34240699 | DOI:10.2807/1560-7917.ES.2021.26.27.2100626 (S...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Sarah V Williams Amoolya Vusirikala Shamez N Ladhani Elena Fernandez Ruiz De Olano Nalini Iyanger Felicity Aiano Kelly Stoker Guduru Gopal Rao Laurence John Bharat Patel Nick Andrews Gavin Dabrera Mary Ramsay Kevin E Brown Jamie Lopez Bernal Vanessa Salib Source Type: research

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.ABSTRACTUsing numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative instantaneous reproduction numbers (RRI) of the R.1, Alpha, and Delta variants with respect to other strains circulating in Japan were estimated at 1.25, 1.44, and 1.95. Depending on the assumed serial interval distributions, RRI varies from 1.20-1.32 for R.1, 1.34-1.58 for Alpha, and 1.70-2.30 for Delta. The frequency of Delta is expected to take over Alpha in Japan before 23 July 2021.PMID:34240695 | DOI:10.2807/1560-7917.ES.2021.26.27.2100570 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Kimihito Ito Chayada Piantham Hiroshi Nishiura Source Type: research

Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
ConclusionNanopore metagenomic sequencing can detect the emergence of novel variants and drug resistance, providing timely insights into antimicrobial stewardship and vaccine design. Full genome generation can help investigate and manage nosocomial outbreaks.PMID:34240696 | DOI:10.2807/1560-7917.ES.2021.26.27.2000004 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Yifei Xu Kuiama Lewandowski Louise O Downs James Kavanagh Thomas Hender Sheila Lumley Katie Jeffery Dona Foster Nicholas D Sanderson Ali Vaughan Marcus Morgan Richard Vipond Miles Carroll Timothy Peto Derrick Crook A Sarah Walker Philippa C Matthews Steve Source Type: research

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100568.ABSTRACTWe compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Dung Nguyen Peter Simmonds Maurice Steenhuis Elise Wouters Daniel Desmecht Mutien Garigliany Marta Romano Cyril Barbezange Piet Maes Bram Van Holm Joaqu ín Mendoza Salvador Oyonarte Anders Fomsgaard Ria Lassauni ère Eva Zusinaite Katarina Resman Rus Tat Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2107081.NO ABSTRACTPMID:34240698 | DOI:10.2807/1560-7917.ES.2021.26.27.2107081 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100626.ABSTRACTWe investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.PMID:34240699 | DOI:10.2807/1560-7917.ES.2021.26.27.2100626 (S...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Sarah V Williams Amoolya Vusirikala Shamez N Ladhani Elena Fernandez Ruiz De Olano Nalini Iyanger Felicity Aiano Kelly Stoker Guduru Gopal Rao Laurence John Bharat Patel Nick Andrews Gavin Dabrera Mary Ramsay Kevin E Brown Jamie Lopez Bernal Vanessa Salib Source Type: research

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.ABSTRACTUsing numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative instantaneous reproduction numbers (RRI) of the R.1, Alpha, and Delta variants with respect to other strains circulating in Japan were estimated at 1.25, 1.44, and 1.95. Depending on the assumed serial interval distributions, RRI varies from 1.20-1.32 for R.1, 1.34-1.58 for Alpha, and 1.70-2.30 for Delta. The frequency of Delta is expected to take over Alpha in Japan before 23 July 2021.PMID:34240695 | DOI:10.2807/1560-7917.ES.2021.26.27.2100570 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Kimihito Ito Chayada Piantham Hiroshi Nishiura Source Type: research

Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
ConclusionNanopore metagenomic sequencing can detect the emergence of novel variants and drug resistance, providing timely insights into antimicrobial stewardship and vaccine design. Full genome generation can help investigate and manage nosocomial outbreaks.PMID:34240696 | DOI:10.2807/1560-7917.ES.2021.26.27.2000004 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Yifei Xu Kuiama Lewandowski Louise O Downs James Kavanagh Thomas Hender Sheila Lumley Katie Jeffery Dona Foster Nicholas D Sanderson Ali Vaughan Marcus Morgan Richard Vipond Miles Carroll Timothy Peto Derrick Crook A Sarah Walker Philippa C Matthews Steve Source Type: research

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100568.ABSTRACTWe compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Dung Nguyen Peter Simmonds Maurice Steenhuis Elise Wouters Daniel Desmecht Mutien Garigliany Marta Romano Cyril Barbezange Piet Maes Bram Van Holm Joaqu ín Mendoza Salvador Oyonarte Anders Fomsgaard Ria Lassauni ère Eva Zusinaite Katarina Resman Rus Tat Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2107081.NO ABSTRACTPMID:34240698 | DOI:10.2807/1560-7917.ES.2021.26.27.2107081 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100626.ABSTRACTWe investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.PMID:34240699 | DOI:10.2807/1560-7917.ES.2021.26.27.2100626 (S...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Sarah V Williams Amoolya Vusirikala Shamez N Ladhani Elena Fernandez Ruiz De Olano Nalini Iyanger Felicity Aiano Kelly Stoker Guduru Gopal Rao Laurence John Bharat Patel Nick Andrews Gavin Dabrera Mary Ramsay Kevin E Brown Jamie Lopez Bernal Vanessa Salib Source Type: research

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.ABSTRACTUsing numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative instantaneous reproduction numbers (RRI) of the R.1, Alpha, and Delta variants with respect to other strains circulating in Japan were estimated at 1.25, 1.44, and 1.95. Depending on the assumed serial interval distributions, RRI varies from 1.20-1.32 for R.1, 1.34-1.58 for Alpha, and 1.70-2.30 for Delta. The frequency of Delta is expected to take over Alpha in Japan before 23 July 2021.PMID:34240695 | DOI:10.2807/1560-7917.ES.2021.26.27.2100570 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Kimihito Ito Chayada Piantham Hiroshi Nishiura Source Type: research

Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
ConclusionNanopore metagenomic sequencing can detect the emergence of novel variants and drug resistance, providing timely insights into antimicrobial stewardship and vaccine design. Full genome generation can help investigate and manage nosocomial outbreaks.PMID:34240696 | DOI:10.2807/1560-7917.ES.2021.26.27.2000004 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Yifei Xu Kuiama Lewandowski Louise O Downs James Kavanagh Thomas Hender Sheila Lumley Katie Jeffery Dona Foster Nicholas D Sanderson Ali Vaughan Marcus Morgan Richard Vipond Miles Carroll Timothy Peto Derrick Crook A Sarah Walker Philippa C Matthews Steve Source Type: research

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100568.ABSTRACTWe compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Dung Nguyen Peter Simmonds Maurice Steenhuis Elise Wouters Daniel Desmecht Mutien Garigliany Marta Romano Cyril Barbezange Piet Maes Bram Van Holm Joaqu ín Mendoza Salvador Oyonarte Anders Fomsgaard Ria Lassauni ère Eva Zusinaite Katarina Resman Rus Tat Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2107081.NO ABSTRACTPMID:34240698 | DOI:10.2807/1560-7917.ES.2021.26.27.2107081 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100626.ABSTRACTWe investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.PMID:34240699 | DOI:10.2807/1560-7917.ES.2021.26.27.2100626 (S...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Sarah V Williams Amoolya Vusirikala Shamez N Ladhani Elena Fernandez Ruiz De Olano Nalini Iyanger Felicity Aiano Kelly Stoker Guduru Gopal Rao Laurence John Bharat Patel Nick Andrews Gavin Dabrera Mary Ramsay Kevin E Brown Jamie Lopez Bernal Vanessa Salib Source Type: research

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100570.ABSTRACTUsing numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative instantaneous reproduction numbers (RRI) of the R.1, Alpha, and Delta variants with respect to other strains circulating in Japan were estimated at 1.25, 1.44, and 1.95. Depending on the assumed serial interval distributions, RRI varies from 1.20-1.32 for R.1, 1.34-1.58 for Alpha, and 1.70-2.30 for Delta. The frequency of Delta is expected to take over Alpha in Japan before 23 July 2021.PMID:34240695 | DOI:10.2807/1560-7917.ES.2021.26.27.2100570 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Kimihito Ito Chayada Piantham Hiroshi Nishiura Source Type: research

Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
ConclusionNanopore metagenomic sequencing can detect the emergence of novel variants and drug resistance, providing timely insights into antimicrobial stewardship and vaccine design. Full genome generation can help investigate and manage nosocomial outbreaks.PMID:34240696 | DOI:10.2807/1560-7917.ES.2021.26.27.2000004 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Yifei Xu Kuiama Lewandowski Louise O Downs James Kavanagh Thomas Hender Sheila Lumley Katie Jeffery Dona Foster Nicholas D Sanderson Ali Vaughan Marcus Morgan Richard Vipond Miles Carroll Timothy Peto Derrick Crook A Sarah Walker Philippa C Matthews Steve Source Type: research

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100568.ABSTRACTWe compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Dung Nguyen Peter Simmonds Maurice Steenhuis Elise Wouters Daniel Desmecht Mutien Garigliany Marta Romano Cyril Barbezange Piet Maes Bram Van Holm Joaqu ín Mendoza Salvador Oyonarte Anders Fomsgaard Ria Lassauni ère Eva Zusinaite Katarina Resman Rus Tat Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2107081.NO ABSTRACTPMID:34240698 | DOI:10.2807/1560-7917.ES.2021.26.27.2107081 (Source: Euro Surveill)
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
Euro Surveill. 2021 Jul;26(27). doi: 10.2807/1560-7917.ES.2021.26.27.2100626.ABSTRACTWe investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.PMID:34240699 | DOI:10.2807/1560-7917.ES.2021.26.27.2100626 (S...
Source: Euro Surveill - July 9, 2021 Category: Infectious Diseases Authors: Sarah V Williams Amoolya Vusirikala Shamez N Ladhani Elena Fernandez Ruiz De Olano Nalini Iyanger Felicity Aiano Kelly Stoker Guduru Gopal Rao Laurence John Bharat Patel Nick Andrews Gavin Dabrera Mary Ramsay Kevin E Brown Jamie Lopez Bernal Vanessa Salib Source Type: research

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.ABSTRACTSARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, Delta 2.1 and 2.6. The reduction of the Alpha (B.1.1.7) variant was not significant. Despite being lower, remaining neutralisation capacity conferred by Comirnaty agains...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Yaniv Lustig Neta Zuckerman Ital Nemet Nofar Atari Limor Kliker Gili Regev-Yochay Einav Sapir Orna Mor Sharon Alroy-Preis Ella Mendelson Michal Mandelboim Source Type: research

A case of < em > bla < /em > NDM-1-positive < em > Salmonella < /em > Kottbus, Denmark, November 2020
We present a case of carbapenemase-producing blaNDM-1-positive Salmonella Kottbus in an 82-year-old Danish man. The blaNDM-1 was also identified in Escherichia coli and Citrobacter freundii in the same patient on the same 43 kb IncN2 plasmid, suggesting in vivo inter-species plasmid transfer. A NCBI BLAST analysis of the plasmid (pAMA003584_NDM-1) identified 12 highly similar plasmids, all originating from east and south-east Asia. This case could be the first confirmed case of blaNDM-1-positive Salmonella not related to travel outside Europe.PMID:34212839 | DOI:10.2807/1560-7917.ES.2021.26.26.2100569 (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Hans Linde Nielsen Philip K Thomsen Eva Litrup Mia Torpdahl S øren Overballe-Petersen Frank Hansen Anne Kathrine Schultz Christensen Henrik Hasman Source Type: research

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100533.ABSTRACTThrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefit...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: C écile Tran Kiem Alessio Andronico Paolo Bosetti Juliette Paireau Lise Alter Pierre-Yves Bo ëlle Arnaud Fontanet Daniel L évy-Bruhl Simon Cauchemez Source Type: research

Trend in mandatory immunisation coverage: linear and joinpoint regression approach, Serbia, 2000 to 2017
This study examined the trends of mandatory vaccination coverage in the period 2000-2017 in Serbia.MethodsData on completed immunisations were retrieved from annual national reports of the Institute of Public Health of Serbia during the period 2000-2017. To assess the trends of immunisation coverage, both linear and joinpoint regression analyses were performed. A probability p
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Marko Veljkovic Goranka Loncarevic Milena Kanazir Darija Kisic-Tepavcevic Tatjana Gazibara Source Type: research

Erratum for Euro Surveill. 2021;26(24)
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.210701e.NO ABSTRACTPMID:34212842 | DOI:10.2807/1560-7917.ES.2021.26.26.210701e (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.1900736.ABSTRACTOn 1 May 2018, a pertussis outbreak was declared and widespread vaccination recommended at an all-female secondary boarding school in southern England. We conducted a retrospective cohort study to determine the extent of pertussis transmission and identify risk factors in this semi-closed population. Of 504 students and staff assessed before post-exposure vaccination, 48% (n = 240) had evidence of pertussis. A sub-analysis of 409 students found that both residential dormitory (p = 0.05) and school year (p = 0.03) were associated with pertu...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Matt Edmunds Rachel Mearkle Jennifer Folliard Charlotte Anderson Sooria Balasegaram Nastassya Chandra Clare Sawyer Norman K Fry Sonia Ribeiro Gemma Palmer Michael Morgan Gill Underhill Nusreen Ahmad Simon Friar Andre Charlett David Litt Colin S Brown Gaya Source Type: research

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.ABSTRACTSARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, Delta 2.1 and 2.6. The reduction of the Alpha (B.1.1.7) variant was not significant. Despite being lower, remaining neutralisation capacity conferred by Comirnaty agains...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Yaniv Lustig Neta Zuckerman Ital Nemet Nofar Atari Limor Kliker Gili Regev-Yochay Einav Sapir Orna Mor Sharon Alroy-Preis Ella Mendelson Michal Mandelboim Source Type: research

A case of < em > bla < /em > NDM-1-positive < em > Salmonella < /em > Kottbus, Denmark, November 2020
We present a case of carbapenemase-producing blaNDM-1-positive Salmonella Kottbus in an 82-year-old Danish man. The blaNDM-1 was also identified in Escherichia coli and Citrobacter freundii in the same patient on the same 43 kb IncN2 plasmid, suggesting in vivo inter-species plasmid transfer. A NCBI BLAST analysis of the plasmid (pAMA003584_NDM-1) identified 12 highly similar plasmids, all originating from east and south-east Asia. This case could be the first confirmed case of blaNDM-1-positive Salmonella not related to travel outside Europe.PMID:34212839 | DOI:10.2807/1560-7917.ES.2021.26.26.2100569 (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Hans Linde Nielsen Philip K Thomsen Eva Litrup Mia Torpdahl S øren Overballe-Petersen Frank Hansen Anne Kathrine Schultz Christensen Henrik Hasman Source Type: research

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100533.ABSTRACTThrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefit...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: C écile Tran Kiem Alessio Andronico Paolo Bosetti Juliette Paireau Lise Alter Pierre-Yves Bo ëlle Arnaud Fontanet Daniel L évy-Bruhl Simon Cauchemez Source Type: research

Trend in mandatory immunisation coverage: linear and joinpoint regression approach, Serbia, 2000 to 2017
This study examined the trends of mandatory vaccination coverage in the period 2000-2017 in Serbia.MethodsData on completed immunisations were retrieved from annual national reports of the Institute of Public Health of Serbia during the period 2000-2017. To assess the trends of immunisation coverage, both linear and joinpoint regression analyses were performed. A probability p
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Marko Veljkovic Goranka Loncarevic Milena Kanazir Darija Kisic-Tepavcevic Tatjana Gazibara Source Type: research

Erratum for Euro Surveill. 2021;26(24)
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.210701e.NO ABSTRACTPMID:34212842 | DOI:10.2807/1560-7917.ES.2021.26.26.210701e (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.1900736.ABSTRACTOn 1 May 2018, a pertussis outbreak was declared and widespread vaccination recommended at an all-female secondary boarding school in southern England. We conducted a retrospective cohort study to determine the extent of pertussis transmission and identify risk factors in this semi-closed population. Of 504 students and staff assessed before post-exposure vaccination, 48% (n = 240) had evidence of pertussis. A sub-analysis of 409 students found that both residential dormitory (p = 0.05) and school year (p = 0.03) were associated with pertu...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Matt Edmunds Rachel Mearkle Jennifer Folliard Charlotte Anderson Sooria Balasegaram Nastassya Chandra Clare Sawyer Norman K Fry Sonia Ribeiro Gemma Palmer Michael Morgan Gill Underhill Nusreen Ahmad Simon Friar Andre Charlett David Litt Colin S Brown Gaya Source Type: research

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.ABSTRACTSARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, Delta 2.1 and 2.6. The reduction of the Alpha (B.1.1.7) variant was not significant. Despite being lower, remaining neutralisation capacity conferred by Comirnaty agains...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Yaniv Lustig Neta Zuckerman Ital Nemet Nofar Atari Limor Kliker Gili Regev-Yochay Einav Sapir Orna Mor Sharon Alroy-Preis Ella Mendelson Michal Mandelboim Source Type: research

A case of < em > bla < /em > NDM-1-positive < em > Salmonella < /em > Kottbus, Denmark, November 2020
We present a case of carbapenemase-producing blaNDM-1-positive Salmonella Kottbus in an 82-year-old Danish man. The blaNDM-1 was also identified in Escherichia coli and Citrobacter freundii in the same patient on the same 43 kb IncN2 plasmid, suggesting in vivo inter-species plasmid transfer. A NCBI BLAST analysis of the plasmid (pAMA003584_NDM-1) identified 12 highly similar plasmids, all originating from east and south-east Asia. This case could be the first confirmed case of blaNDM-1-positive Salmonella not related to travel outside Europe.PMID:34212839 | DOI:10.2807/1560-7917.ES.2021.26.26.2100569 (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Hans Linde Nielsen Philip K Thomsen Eva Litrup Mia Torpdahl S øren Overballe-Petersen Frank Hansen Anne Kathrine Schultz Christensen Henrik Hasman Source Type: research

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100533.ABSTRACTThrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefit...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: C écile Tran Kiem Alessio Andronico Paolo Bosetti Juliette Paireau Lise Alter Pierre-Yves Bo ëlle Arnaud Fontanet Daniel L évy-Bruhl Simon Cauchemez Source Type: research

Trend in mandatory immunisation coverage: linear and joinpoint regression approach, Serbia, 2000 to 2017
This study examined the trends of mandatory vaccination coverage in the period 2000-2017 in Serbia.MethodsData on completed immunisations were retrieved from annual national reports of the Institute of Public Health of Serbia during the period 2000-2017. To assess the trends of immunisation coverage, both linear and joinpoint regression analyses were performed. A probability p
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Marko Veljkovic Goranka Loncarevic Milena Kanazir Darija Kisic-Tepavcevic Tatjana Gazibara Source Type: research

Erratum for Euro Surveill. 2021;26(24)
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.210701e.NO ABSTRACTPMID:34212842 | DOI:10.2807/1560-7917.ES.2021.26.26.210701e (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.1900736.ABSTRACTOn 1 May 2018, a pertussis outbreak was declared and widespread vaccination recommended at an all-female secondary boarding school in southern England. We conducted a retrospective cohort study to determine the extent of pertussis transmission and identify risk factors in this semi-closed population. Of 504 students and staff assessed before post-exposure vaccination, 48% (n = 240) had evidence of pertussis. A sub-analysis of 409 students found that both residential dormitory (p = 0.05) and school year (p = 0.03) were associated with pertu...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Matt Edmunds Rachel Mearkle Jennifer Folliard Charlotte Anderson Sooria Balasegaram Nastassya Chandra Clare Sawyer Norman K Fry Sonia Ribeiro Gemma Palmer Michael Morgan Gill Underhill Nusreen Ahmad Simon Friar Andre Charlett David Litt Colin S Brown Gaya Source Type: research

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.ABSTRACTSARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, Delta 2.1 and 2.6. The reduction of the Alpha (B.1.1.7) variant was not significant. Despite being lower, remaining neutralisation capacity conferred by Comirnaty agains...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Yaniv Lustig Neta Zuckerman Ital Nemet Nofar Atari Limor Kliker Gili Regev-Yochay Einav Sapir Orna Mor Sharon Alroy-Preis Ella Mendelson Michal Mandelboim Source Type: research

A case of < em > bla < /em > NDM-1-positive < em > Salmonella < /em > Kottbus, Denmark, November 2020
We present a case of carbapenemase-producing blaNDM-1-positive Salmonella Kottbus in an 82-year-old Danish man. The blaNDM-1 was also identified in Escherichia coli and Citrobacter freundii in the same patient on the same 43 kb IncN2 plasmid, suggesting in vivo inter-species plasmid transfer. A NCBI BLAST analysis of the plasmid (pAMA003584_NDM-1) identified 12 highly similar plasmids, all originating from east and south-east Asia. This case could be the first confirmed case of blaNDM-1-positive Salmonella not related to travel outside Europe.PMID:34212839 | DOI:10.2807/1560-7917.ES.2021.26.26.2100569 (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Hans Linde Nielsen Philip K Thomsen Eva Litrup Mia Torpdahl S øren Overballe-Petersen Frank Hansen Anne Kathrine Schultz Christensen Henrik Hasman Source Type: research

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100533.ABSTRACTThrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefit...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: C écile Tran Kiem Alessio Andronico Paolo Bosetti Juliette Paireau Lise Alter Pierre-Yves Bo ëlle Arnaud Fontanet Daniel L évy-Bruhl Simon Cauchemez Source Type: research

Trend in mandatory immunisation coverage: linear and joinpoint regression approach, Serbia, 2000 to 2017
This study examined the trends of mandatory vaccination coverage in the period 2000-2017 in Serbia.MethodsData on completed immunisations were retrieved from annual national reports of the Institute of Public Health of Serbia during the period 2000-2017. To assess the trends of immunisation coverage, both linear and joinpoint regression analyses were performed. A probability p
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Marko Veljkovic Goranka Loncarevic Milena Kanazir Darija Kisic-Tepavcevic Tatjana Gazibara Source Type: research

Erratum for Euro Surveill. 2021;26(24)
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.210701e.NO ABSTRACTPMID:34212842 | DOI:10.2807/1560-7917.ES.2021.26.26.210701e (Source: Euro Surveill)
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.1900736.ABSTRACTOn 1 May 2018, a pertussis outbreak was declared and widespread vaccination recommended at an all-female secondary boarding school in southern England. We conducted a retrospective cohort study to determine the extent of pertussis transmission and identify risk factors in this semi-closed population. Of 504 students and staff assessed before post-exposure vaccination, 48% (n = 240) had evidence of pertussis. A sub-analysis of 409 students found that both residential dormitory (p = 0.05) and school year (p = 0.03) were associated with pertu...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Matt Edmunds Rachel Mearkle Jennifer Folliard Charlotte Anderson Sooria Balasegaram Nastassya Chandra Clare Sawyer Norman K Fry Sonia Ribeiro Gemma Palmer Michael Morgan Gill Underhill Nusreen Ahmad Simon Friar Andre Charlett David Litt Colin S Brown Gaya Source Type: research

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.ABSTRACTSARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, Delta 2.1 and 2.6. The reduction of the Alpha (B.1.1.7) variant was not significant. Despite being lower, remaining neutralisation capacity conferred by Comirnaty agains...
Source: Euro Surveill - July 2, 2021 Category: Infectious Diseases Authors: Yaniv Lustig Neta Zuckerman Ital Nemet Nofar Atari Limor Kliker Gili Regev-Yochay Einav Sapir Orna Mor Sharon Alroy-Preis Ella Mendelson Michal Mandelboim Source Type: research